| Financial Year |
March 31 2023 |
| Monetary Funds |
545,555,389.54 |
| Held-for-trading Financial Assets |
115,066,164.38 |
| Notes Receivable |
-- |
| Accounts Receivable |
167,807,642.58 |
| Advances to Suppliers |
16,023,927.58 |
| Other Receivables |
4,582,079.49 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
209,651,411.28 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
6,536,106.76 |
| Total Current Assets |
1,076,438,234.15 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
14,449,976.95 |
| Investment Properties |
31,342,380.68 |
| Fixed Assetes |
325,798,741.28 |
| Under-construction Projects |
35,412,386.97 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
132,092,922.93 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
25,008,055.65 |
| Other Non-Current Assets |
3,521,342.95 |
| Sub-Total of Non-Current Assets |
573,820,435.07 |
| Total Assets |
1,650,258,669.22 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
35,170,482.91 |
| Accounts Payable |
103,962,086.41 |
| Accounts Received In Advance |
391,974.36 |
| Employee Compensation Payable |
22,529,114.45 |
| Taxes Payable |
10,022,219.58 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
8,284,444.88 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
198,023.12 |
| Other Current Liabilities |
4,523,686.09 |
| Sub-Total of Current Liabilities |
230,648,749.52 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
335,562.50 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
99,329,257.80 |
| Total Liabilities |
329,978,007.32 |
| Paid-In Capital(Or Share Stock) |
184,259,858.00 |
| Capital Surplus |
650,696,681.73 |
| Surplus Reserve |
74,592,559.37 |
| LESS:Treasury Stock |
26,065,982.99 |
| Undistributed Profits |
434,436,375.73 |
| Minority Stockholder's Interest |
-847,288.32 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,321,127,950.22 |
| Owner's Equity（Stockholder's Equity） |
1,320,280,661.90 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,650,258,669.22 |
